摘要
Objective To examine the effects of temsirolimus, an inhibitor of mammalian target of rapamycin,on bladder cancer cell lines T24 and BIU-87 in vitro and in vivo for purpose of evaluating the probability of mTOR targeted therapy for bladder cancer. Methods After
出处
《外科研究与新技术》
2011年第4期247-248,共2页
Surgical Research and New Technique
